MiMedx Group, Inc.

MDXG · NasdaqCM

Price$0.00+0.00 (+0.00%)

Price History

Volume & Moving Averages

Price50D200D

Analyst Price Target

$0.00▲ 0.0% above current price

Range: $0.00 – $0.00 · 0 analysts

Based on Wall Street analyst estimates — not a Stockinder prediction.

About the company

Jarvis is thinking

Key Metrics

Report card

Open as standalone page ↗

Jarvis is thinking

Recent Notable Coverage

Jarvis is thinking

Report Card

Growth

Health

Risk

Value

Quality

Ownership

Insider and institutional holdings, from Yahoo Finance — for Indian companies this roughly tracks promoter (insiders) and combined FII/DII (institutions) stakes, though not split out the same way a shareholding-pattern filing would.

Insiders2.1%

Institutions77.6%

Public / Other

Income Statement

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2016-12-31	2015-12-31
Total money the company brought in from its core business during the period, before any costs are subtracted.	$418.63M	$348.88M	$321.48M	$267.84M	$258.62M	$248.23M	$299.25M	$359.11M	$245.01M	$187.30M
The direct costs of producing what was sold — raw materials, manufacturing, direct labor.	$73.01M	$60.07M	$54.63M	$48.32M	$43.28M	$39.33M	$43.08M	$36.39M	$32.41M	$20.20M
Revenue left after subtracting the direct cost of producing goods or services — how efficiently the core business converts sales into profit before overhead.	$345.62M	$288.81M	$266.84M	$219.53M	$215.33M	$208.90M	$256.17M	$322.73M	$212.61M	$167.09M
Gross profit as a percentage of revenue.	82.6%	82.8%	83.0%	82.0%	83.3%	84.2%	85.6%	89.9%	86.8%	89.2%
Profit from core operations after subtracting the cost of revenue and operating expenses like R&D and marketing, but before interest and taxes.	$63.89M	$58.87M	$37.12M	-$24.97M	-$5.04M	-$45.40M	-$21.16M	-$3.90M	$18.45M	$24.36M
Operating income as a percentage of revenue.	15.3%	16.9%	11.5%	-9.3%	-1.9%	-18.3%	-7.1%	-1.1%	7.5%	13.0%
The company's bottom-line profit after all expenses, interest, and taxes are subtracted.	$48.58M	$42.42M	$58.23M	-$30.20M	-$10.29M	-$49.28M	-$25.58M	-$29.98M	$11.97M	$29.45M
Net income divided by the number of shares outstanding — profit attributable to each share.	$0.33	$0.29	$0.40	$-0.33	$-0.15	$-0.77	$-0.24	$-0.28	$0.00	$0.00
Like basic EPS, but accounts for shares that could be created from stock options or convertible securities — a more conservative per-share profit figure.	$0.32	$0.28	$0.37	$-0.33	$-0.15	$-0.77	$-0.24	$-0.28	$0.00	$0.00

Balance Sheet

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2016-12-31	2015-12-31
Cash and highly liquid short-term investments the company can access almost immediately.	$166.12M	$104.42M	$82.00M	$65.95M	$87.08M	$95.81M	$69.10M	$45.10M	$34.39M	$28.49M
Everything the company owns that has value — cash, property, inventory, investments, and more.	$342.65M	$263.92M	$239.05M	$171.43M	$187.93M	$202.03M	$167.17M	$122.84M	$193.26M	$135.91M
All of the company's interest-bearing borrowings, short and long term combined.	$17.97M	$18.83M	$48.10M	$48.59M	$48.13M	$47.70M	$65.66M	–	–	–
Everything the company owes — debt, unpaid bills, and other obligations.	$86.11M	$70.81M	$96.33M	$96.92M	$95.35M	$110.61M	$132.77M	$73.19M	$60.26M	$27.93M
What would be left for shareholders if the company sold all its assets and paid off all its debts — total assets minus total liabilities.	$256.55M	$193.11M	$142.72M	-$17.99M	$82000	-$150000	$34.40M	$49.66M	$133.00M	$107.99M

Cash Flow Statement

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2016-12-31	2015-12-31
Actual cash generated by the core business, as opposed to accounting profit, which can include non-cash items.	$74.00M	$67.13M	$34.94M	-$17.89M	-$1.98M	-$30.26M	-$39.41M	$35.80M	$25.83M	$18.81M
Cash spent on physical assets like property, equipment, and infrastructure to maintain or grow the business.	–	–	$1.99M	–	–	–	–	–	–	–
Cash left over after capital expenditures — money the company could use for dividends, buybacks, debt repayment, or reinvestment.	–	–	$32.95M	–	–	–	–	–	–	–

	You	Peer avg
P/E	114.3	5.4
Revenue Growth	-34.7%	+32.6%
ROE	2.9%	-35.3%

MiMedx Group, Inc.

Price History

Volume & Moving Averages

Analyst Price Target

About the company

Key Metrics

Report card

Jarvis Analysis

Recent Notable Coverage

Report Card

Ownership

Quick Actions

Reports & Coverage

Con Call Reports

Board of Directors / Annual Reports

Recent Articles

Income Statement

Balance Sheet

Cash Flow Statement

Peer Comparison